SAR-446523

N/A

Report date: 2025/10/23 10:45:31

Base Information

Drug NameSAR-446523
Drug Alias NameSAR-446523
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-GPRC5D
TargetsG-protein coupled receptor family C group 5member D
Therapy Area/IndicationsBone Marrow NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[8] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSanofi-Aventis Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesSanofi-Aventis GmbhSanofiSanofi-Aventis Recherche & Developpement
Inactive CompaniesN/A
Active IndicationsBone Marrow NeoplasmsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A